Docusign Inc. $DOCU Holdings Cut by Parallel Advisors LLC

Parallel Advisors LLC lowered its holdings in Docusign Inc. (NASDAQ:DOCU) by 43.2% during the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 2,705 shares of the company’s stock after selling 2,059 shares during the period. Parallel Advisors LLC’s holdings in Docusign were worth $211,000 at the end of the most recent quarter.

Several other large investors also recently made changes to their positions in the company. American Century Companies Inc. increased its stake in shares of Docusign by 3.1% in the first quarter. American Century Companies Inc. now owns 5,477,758 shares of the company’s stock valued at $445,890,000 after purchasing an additional 162,299 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its stake in shares of Docusign by 18.6% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 2,028,505 shares of the company’s stock valued at $165,120,000 after acquiring an additional 318,698 shares during the period. Wellington Management Group LLP increased its stake in shares of Docusign by 372.5% during the first quarter. Wellington Management Group LLP now owns 1,826,949 shares of the company’s stock valued at $148,714,000 after acquiring an additional 1,440,269 shares during the period. Charles Schwab Investment Management Inc. increased its stake in shares of Docusign by 6.7% during the first quarter. Charles Schwab Investment Management Inc. now owns 1,431,901 shares of the company’s stock valued at $116,557,000 after acquiring an additional 89,948 shares during the period. Finally, Pacer Advisors Inc. increased its stake in shares of Docusign by 809.6% during the first quarter. Pacer Advisors Inc. now owns 1,167,290 shares of the company’s stock valued at $95,017,000 after acquiring an additional 1,038,962 shares during the period. Institutional investors and hedge funds own 77.64% of the company’s stock.

Analysts Set New Price Targets

DOCU has been the topic of a number of research analyst reports. JPMorgan Chase & Co. raised their price objective on shares of Docusign from $77.00 to $80.00 and gave the company a “neutral” rating in a research note on Friday, September 5th. Morgan Stanley raised their price objective on shares of Docusign from $86.00 to $90.00 and gave the company an “equal weight” rating in a research note on Monday, September 8th. Wedbush lowered their price objective on shares of Docusign from $100.00 to $85.00 and set a “neutral” rating on the stock in a research note on Thursday, June 12th. Zacks Research upgraded shares of Docusign from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, September 9th. Finally, Needham & Company LLC restated a “hold” rating on shares of Docusign in a research report on Friday, September 5th. One equities research analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating and fourteen have issued a Hold rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average target price of $94.14.

Docusign Stock Performance

NASDAQ:DOCU opened at $84.86 on Tuesday. The company has a market cap of $17.07 billion, a price-to-earnings ratio of 63.80, a PEG ratio of 4.43 and a beta of 1.02. The firm’s 50-day moving average is $76.56 and its 200-day moving average is $79.31. Docusign Inc. has a 52-week low of $58.00 and a 52-week high of $107.86.

Docusign (NASDAQ:DOCU) last posted its earnings results on Thursday, September 4th. The company reported $0.92 earnings per share for the quarter, beating analysts’ consensus estimates of $0.84 by $0.08. The business had revenue of $800.64 million for the quarter, compared to analysts’ expectations of $780.35 million. Docusign had a net margin of 9.08% and a return on equity of 14.01%. The firm’s revenue for the quarter was up 8.8% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.97 earnings per share. Docusign has set its Q3 2026 guidance at EPS. FY 2026 guidance at EPS. Equities analysts predict that Docusign Inc. will post 1.17 EPS for the current year.

Docusign announced that its Board of Directors has approved a share repurchase plan on Thursday, June 5th that permits the company to repurchase $1.00 billion in shares. This repurchase authorization permits the company to buy up to 6.6% of its stock through open market purchases. Stock repurchase plans are typically an indication that the company’s board of directors believes its stock is undervalued.

Insider Buying and Selling at Docusign

In other news, Director Peter Solvik sold 15,000 shares of the stock in a transaction on Monday, September 15th. The shares were sold at an average price of $81.48, for a total transaction of $1,222,200.00. Following the completion of the sale, the director owned 135,253 shares of the company’s stock, valued at $11,020,414.44. This represents a 9.98% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CFO Blake Jeffrey Grayson sold 9,509 shares of the stock in a transaction on Wednesday, September 17th. The stock was sold at an average price of $83.10, for a total transaction of $790,197.90. Following the transaction, the chief financial officer owned 112,160 shares of the company’s stock, valued at $9,320,496. The trade was a 7.82% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 82,533 shares of company stock valued at $6,598,028 over the last 90 days. Company insiders own 1.66% of the company’s stock.

Docusign Profile

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.